Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 5/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953271 | 0.87 | MME (0.34) | NR3C2LMNARAB9AKDM4EMMP13 | |
| SCHEMBL30953522 | 0.85 | AAK1 (0.47) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL30953284 | 0.83 | AAK1 (0.45) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL27393615 | 0.83 | AAK1 (0.48) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL30953221 | 0.83 | AAK1 (0.48) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL30953339 | 0.82 | AAK1 (0.50) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL30953454 | 0.81 | AAK1 (0.43) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL27393526 | 0.81 | AAK1 (0.43) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL30953533 | 0.80 | AAK1 (0.45) | AAK1IGF1RNR3C2LMNARAB9A | |
| SCHEMBL27393604 | 0.78 | AAK1 (0.44) | AAK1IGF1RNR3C2LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |